Document is current

Any future updates will be listed below

Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer: a meta-analysis and systemic review of randomized clinical trials

Crossref DOI link: https://doi.org/10.1007/s11684-020-0795-4

Published Online: 2020-11-11

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark